Ashland Specialty Ingredients v. Lifetech Pharma

CourtDistrict Court, D. Utah
DecidedFebruary 5, 2024
Docket1:22-cv-00080
StatusUnknown

This text of Ashland Specialty Ingredients v. Lifetech Pharma (Ashland Specialty Ingredients v. Lifetech Pharma) is published on Counsel Stack Legal Research, covering District Court, D. Utah primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ashland Specialty Ingredients v. Lifetech Pharma, (D. Utah 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF UTAH

ASHLAND SPECIALTY INGREDIENTS G.P., MEMORANDUM DECISION AND Plaintiff, ORDER GRANTING PLAINTIFF’S MOTION FOR SUMMARY JUDGMENT v. Case No. 1:22-CV-00080-TS-JCB LIFETECH PHARMA, LLC, District Judge Ted Stewart Defendant.

This matter is before the Court on Plaintiff Ashland Specialty Ingredients’ Motion for Summary Judgment on (1) Plaintiff’s Breach of Contract Cause of Action and (2) Defendant’s Affirmative Defenses.1 For the reasons discussed below, the Court grants Plaintiff’s Motion. I. BACKGROUND Plaintiff is a global chemical manufacturing company that manufactures additives and specialty ingredients for use in various industries.2 Defendant LifeTech is a pharmaceutical and medicine manufacturer that manufactures dietary supplements and over the counter products such as hand sanitizers.3 In 2020, Plaintiff and Defendant entered into an agreement wherein Plaintiff agreed to sell to Defendant Klucel Hydroxypropylcellulose (“the Product”), which Defendant intended to use in the manufacture of hand sanitizer. In turn, Defendant agreed to pay for the Product

1 Docket No. 25. 2 Id. at 1. 3 Id. according to the rates and terms agreed upon by parties.4 Plaintiff alleges that, after it timely delivered the goods, Defendant failed to remit payment and thus damaged Plaintiff.5 The statement of undisputed material fact establishes that Plaintiff delivered the Product to Defendant in four releases, and three of those releases remain unpaid.6 Defendant accepted,

without rejection due to nonconformance, delivery of all four releases of the Product, each of which conformed with specifications outlined in the parties’ agreement.7 Despite negotiations between the parties attempting to reach an agreement on the balance owed by Defendant,8 Plaintiff filed the Complaint on June 24, 2022, bringing breach of contract, unjust enrichment, and promissory estoppel claims against Defendant.9 Defendant answered on September 14, 2022, addressing the allegations and bringing several affirmative defenses.10 Plaintiff now moves for summary judgment on (1) Ashland’s first cause of action for breach of contract and (2) Defendant LifeTech Pharma, LLC’s affirmative defenses.11 Defendant filed a Response to the Motion on October 2, 2023, stating it does not oppose Plaintiff’s Motion.12 II. STANDARD OF REVIEW

Summary judgment is appropriate “if the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.”13 In

4 Id. at 1–2. 5 Docket No. 2 ¶¶ 4–6. 6 Docket No. 25 ¶¶ 8–18. 7 Id. ¶¶ 28–31. 8 Id. ¶¶ 33–47. 9 Docket No. 2. 10 Docket No. 7. 11 Docket No. 25, at 1. 12 Docket No. 27. 13 Fed. R. Civ. P. 56(a). considering whether a genuine dispute of material fact exists, the Court determines whether a reasonable jury could return a verdict for the nonmoving party in the face of all the evidence presented.14 The Court is required to construe all facts and reasonable inferences in the light most favorable to the nonmoving party.15

In a summary judgment motion, the nonmoving party’s non-opposition does not permit a district court to automatically grant the motion. Instead, the Court must examine “the moving party’s submission to determine if it has met its initial burden of demonstrating that no material issues of fact remain for trial and the moving party is entitled to judgment as a matter of law.”16 III. DISCUSSION A. Breach of Contract Claim The parties’ agreement provides that it is to be governed by the laws of the State of New York.17 To prevail on a claim for breach of contract, New York law requires Plaintiff to prove “(1) the existence of a contract; (2) performance of the contract by one party; (3) breach by the other party; and (4) damages.”18 Because the contract at issue involves the sale of goods, Article 2 of the Uniform Commercial Code governs the contract.19 First, it is undisputed that the parties had an agreement that constituted a valid and binding contract. Defendant delivered a purchase order to Plaintiff for 19,341.36 kilograms of

14 See Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 249 (1986); Clifton v. Craig, 924 F.2d 182, 183 (10th Cir. 1991). 15 See Matsushita Elec. Indus. Co. v. Zenith Radio Corp., 475 U.S. 574, 587 (1986); Wright v. Sw. Bell Tel. Co., 925 F.2d 1288, 1292 (10th Cir. 1991). 16 Reed v. Bennett, 312 F.3d 1190, 1195 (10th Cir. 2002). 17 Docket No. 25, at 12. 18 LG Cap. Funding, LLC v. M Line Holdings, Inc., 422 F. Supp. 3d 739, 755 (E.D.N.Y. 2018) (internal quotation marks and citation omitted). 19 N.Y. U.C.C. Law § 2-101 (McKinney); see also UCC § 2-101. the Product on May 7, 2020.20 In keeping with Plaintiff’s policy regarding the type of Product requested, Defendant signed specification waivers for the Product it had ordered.21 Plaintiff’s terms and conditions specifying that payment was due within 30 days of receipt were referenced at the bottom of each invoice Defendant received.22 Defendant raised no objection nor identified any disagreement with those terms and conditions or the quality of the delivered Product.23 As

both parties are merchants, the additional terms contained in Plaintiff’s terms and conditions were incorporated into the parties’ agreement due to Defendant’s failure to raise any objections to the terms.24 Defendant also admitted the existence of a contract between the parties in its response to Plaintiff’s interrogatory.25 Therefore, the Court finds that the parties entered into a valid contract requiring Defendant pay the amount due to Plaintiff within 30 days of receipt in exchange for delivery of the Product. Second, there is no dispute that Plaintiff performed on the parties’ contract by delivering the four releases of the Product according to their agreement. The three unpaid releases at issue in the case were received by Defendant on June 25, 2020; June 27, 2020; and July 1, 2020, respectively.26 Defendant accepted delivery of the Product.27 There is no dispute that the Product

20 Docket No. 25 ¶ 5. 21 Id. ¶¶ 6–7. 22 Id. ¶¶ 24–27. 23 Id. ¶¶ 22–27. 24 N.Y. UCC Law § 2-207(2)(a)–(c) (McKinney); Docket No. 26-9 ¶ 4; Docket No. 26- 16 ¶¶ 14–15. 25 Docket No. 26-1, at 4 (“Response: There was a contract between the parties”). 26 Docket No. 25 ¶¶ 9–19. 27 Docket No. 26-1, at 8 (“Response: Admit that Defendant accepted delivery of the first two releases”). conformed with the specifications in the parties’ contract and was merchantable and not defective.28 Thus, the Court finds that Plaintiff properly performed on the parties’ contract. Third, there is no dispute that Defendant breached the parties’ contract by failing to pay for three of the releases of the Product within 30 days of delivery of the respective releases.29

Despite discussions regarding payment of the owed balance between the parties, Defendant has neither paid the balance nor acted on any proposed arrangements to address the remaining balance.30 Therefore, the Court finds that Defendant breached the parties’ contract. Fourth, there is no dispute that Plaintiff was damaged by Defendant’s breach.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Reed v. Bennett
312 F.3d 1190 (Tenth Circuit, 2002)
Raymond Lee Clifton v. Manfred R. Craig
924 F.2d 182 (Tenth Circuit, 1991)
Independent Energy Corp. v. Trigen Energy Corp.
944 F. Supp. 1184 (S.D. New York, 1996)
Kramer v. Greene
142 A.D.3d 438 (Appellate Division of the Supreme Court of New York, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
Ashland Specialty Ingredients v. Lifetech Pharma, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ashland-specialty-ingredients-v-lifetech-pharma-utd-2024.